/AI4h ago

Former White House advisor Dean W. Ball argues recent breakthroughs in gene editing and obesity demand faster FDA approvals

Highlighted treatments include retatrutide and PCSK9 gene editing.

--0--
Quote posts
Nathan 🔎#1902
Reposts
Dean W. Ball#392
Original post
Derek Thompson@DKThomp

This has quietly been a miracle month in medicine.

In the last 5 weeks we’ve got news on:

- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels - RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life - small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol - Mayo’s AI-assisted radiology showing vastly improved cancer detection - this new therapy for metastatic solid tumors

This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.

8:38 AM · May 31, 2026 · 704K Views
Sentiment
Sentiment unavailable for this story.
Cluster Engagement
-
Views
-
Comments
-
Reposts
-
Bookmarks
Expand data
Posts from X
Most Activity
Most ActivityTimeline
VIEWS2KLIKES10
Nathan 🔎@NathanpmYoung

FDA, get out of the way!

Derek Thompson@DKThomp

This has quietly been a miracle month in medicine.

In the last 5 weeks we’ve got news on:

- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels - RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life - small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol - Mayo’s AI-assisted radiology showing vastly improved cancer detection - this new therapy for metastatic solid tumors

This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.

2hViews 2KLikes 10Bookmarks 0
Former White House advisor Dean W. Ball argues recent breakthroughs in gene editing and obesity demand faster FDA approvals · Digg